Immunotherapy for Kidney Cancer

Our latest Town Hall event focused on immunotherapy for kidney cancer patients. See leading oncologists discuss options for kidney cancer.

Just diagnosed? Learn more.

A kidney cancer diagnosis can be scary and confusing. You’re not alone. KidneyCAN has put together resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

Speak Up for Research Funding

Every year, KidneyCAN sends advocates to Washington, D.C., to ask Congress to fund kidney cancer research. Our advocates are patients, caregivers, doctors, and researchers.

We just wrapped up our spring event, but we need people like YOU to join us next time – no experience necessary.

Kidney Cancer Research Summit

KCRS22 will be a hybrid meeting in Philadelphia, Pennsylvania, on October 6-7, 2022. Virtual attendees can register now for free, full access to all sessions.  You can also view video and slides of presentations  from KCRS21.

Making Progress Toward Cures

Our Goals

  • We provide education, resources, and support to kidney cancer patients and caregivers
  • We identify patients’ and researchers’ unmet needs
  • We engage and educate policymakers on the urgency of kidney cancer research funding
  • We urge Congress to fund kidney cancer research
  • We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • We provide direct funding to promising ideas
  • We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • We grow the community of kidney cancer researchers
  • We support the development of new treatments by educating patients on trial access and enrollment
  • We identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

Understanding Your Kidney Cancer Diagnosis

GO TO PAGE

Visit

Building a Care Team

GO TO PAGE

Visit

Treatment & Trial Options

GO TO PAGE

Visit

Living Well with Kidney Cancer

GO TO PAGE

Visit

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

HELP NEEDED!!!
Are you an adult living with advanced #renalcancer or advanced #livercancer ?
We opened our international #survey. Please have your say - help us better understand your ...experiences - make us better for you. 👉https://t.co/Q51eTrFpOT

@nursGK704
@cancernurseEU

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.

▶️ Questions & Support:... What to Bring to Your Kidney Cancer Oncology Appointment

Watch here: https://youtu.be/eSHbG7OeYHg

Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at [email protected]!

For this installment of #KidneyCANDID, Dr. Sumanta Pal of City of Hope shares two things patients can do as they prepare for their #kidneycancer appointments.

▶️ Questions & Support:... What to Bring to Your Kidney Cancer Oncology Appointment

Watch here: https://youtu.be/eSHbG7OeYHg

Have a topic you'd like us to cover in another episode of #KidneyCANDID? Comment below or email us at [email protected]!

Image for shared link
Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointments

In this installment of KidneyCANDID, we get from renowned oncologist Dr. Monty Pal of City of Hope. Dr. Pal shares two pieces of advice for patients...

youtu.be

ICYMI: @montypal, of @cityofhope, discusses research presented at #GU22, including data from TIVO-3 & findings from NeoAvAx exploring avelumab plus axitinib for patients w/ high-risk, ...nonmetastatic clear-cell RCC in a recent episode of #OncLiveOnAir #kcsm https://t.co/XpES1nYOsf

Lets get people talking about “access to treatments for kidney cancer patients “ Join us on 16th June 2022 and raise awareness of the inequities faced by kidney cancer patients around the world ...#WKCD2022 #kidneycancer https://t.co/HHkXyJAJWe

Celebrating clinical trial day! Clinical research is the only way to improve care! Thank you everyone who strives to push this effort ⁦@eaonc⁩ ⁦@BigTenCRC⁩ ⁦@PennStHershey⁩ ...⁦@jlkrasch⁩ ⁦@PGrivasMDPhD⁩⁩ ⁦@shilpaonc⁩ ⁦⁦@ASCOPost⁩

Exciting results with unconventional cabo dose increase may offer hope for stage 4 #kidneycancer patients in need of treatment options; @KCPUTSW partnering with @ExelixisInc to explore clinical ...trial. @utswcancer

https://t.co/LBeV7YqeEq
https://t.co/zQwH7Vltpm

For this installment of #KidneyCANDID, @montypal of @cityofhope shares 2 things patients can do as they prepare for their #kidneycancer appointments.

Questions & Support: What to Bring ...to Your Kidney Cancer Oncology Appoin... via @YouTube

@OncoAlert

Image for twitter card
Questions & Support: What to Bring to Your Kidney Cancer Oncology Appointments

In this installment of KidneyCANDID, we get from renowned oncologist Dr. Monty Pal of City of Hope. Dr. Pal shares two pieces of advice for patients...

youtu.be
When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $135 million in research funding in five years.

Latest News

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader...

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials....

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and...

Tracy’s Story: A Caregiver’s Perspective

Tracy, 56, lives in Northeast Ohio with her wife of 12 years, Julie. Julie was diagnosed in 2014 with stage three clear cell renal cell carcinoma. For this month's Community Spotlight, KidneyCAN spoke to Tracy, whose wife Julie is living with stage four kidney cancer....

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...